QUOTE AND NEWS
PR Newswire  Nov 9  Comment 
ALISO VIEJO, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make presentations
PR Newswire  Nov 5  Comment 
BOTHELL, Wash., Nov. 5 /PRNewswire-FirstCall/ -- Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced today it appointed veteran healthcare
StreetInsider.com  Nov 3  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Clarient+%28CLRT%29+Misses+Q3+EPS+by+5c%3B+Guides+Lower+for+FY+Revenues+-+Below+Consensus/5071258.html for the full story.
PR Newswire  Sep 29  Comment 
ALISO VIEJO, Calif., Sept. 29 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make an investor
PR Newswire  Sep 1  Comment 
ALISO VIEJO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it is scheduled to make investor
StreetInsider.com  Aug 27  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Safeguard+Scientifics+%28SFE%29+Announces+Sale+of+Approximately+One-Third+of+Its+Clarient+%28CLRT%29+Shares+for+Approximately+%2453+Million+in+Proceeds/4904857.html for the...
StreetInsider.com  Aug 4  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Clarient+%28CLRT%29+Misses+Q2+EPS+by+6c/4844288.html for the full story.
StreetInsider.com  Jun 22  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Clarient+%28CLRT%29+Files+for+49.29M+Common+Stock+Offering+by+Shareholders/4746385.html for the full story.
StreetInsider.com  Jun 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Clarient+%28CLRT%29+Launches+New+Gene+Mutation+Test+to+Help+Select+Therapy+for+Non-Small+Cell+Lung+Cancer/4733202.html for the full story.
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
RELATED WIKI ARTICLES

Related Articles


 
CLRT AT A GLANCE
 
 
 
 
 
 
 
 
Clarient (CLRT) provides a services to assess cancer on a cellular level and to characterize the cancer. They primarily focus on solid tumors on the breast, prostate and lung.




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki